We aimed to study radiomics approach based on biparametric magnetic resonance imaging
(MRI) for determining significant residual cancer after androgen deprivation therapy (ADT) …

Background around one third of clinically significant prostate cancer (CsPCa) foci are
reported to be MRI non-visible (MRI─). Objective To quantify the differences between MR …

Purpose To investigate the efficiency of radiomics signature in discriminating between
benign and malignant prostate lesions with similar biparametric magnetic resonance …

Background To evaluate the potential of clinical-based model, a biparametric MRI-based
radiomics model and a clinical-radiomics combined model for predicting clinically significant …

The purpose of this study was to develop Bi-parametric Magnetic Resonance Imaging (BP-
MRI) based radiomics models for differentiation between benign and malignant prostate …

Background: Prostate cancer is the second most common cancer-related cause of death in
men. Accurate diagnosis of prostate cancer plays an important role in decreasing mortality …

Purpose The purpose of this study was to develop and test across various scanners a zone-
specific region-of-interest (ROI)-based computer-aided diagnosis system (CAD) aimed at …

Background Gleason score (GS) is a histologic prognostic factor and the basis of treatment
decision‐making for prostate cancer (PCa). Treatment regimens between lower‐grade …

Results Among 165 radiomics features, 8 features (2 features from Two-Dimensional
Wavelet Transform, 4 features from Two-Dimensional Gabor Filter, 2 features from Gray …

Purpose To compare the performance of radiomics to that of the Prostate Imaging Reporting
and Data System (PI-RADS) v2. 1 scoring system in the detection of clinically significant …